Loading…

Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review

Abstract Background and Aims The inflammatory bowel diseases [IBD], Crohn’s disease and ulcerative colitis, are chronic, idiopathic gastrointestinal diseases. Although their precise aetiology is unknown, it is thought to involve a complex interaction between genetic predisposition and an abnormal ho...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Crohn's and colitis 2021-05, Vol.15 (5), p.813-826
Main Authors: Gallagher, Kate, Catesson, Alexandra, Griffin, Julian L, Holmes, Elaine, Williams, Horace R T
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c443t-d0e2ba3a2723f70522468b6a84fb15b6b9da7624ace2538306a3e45ee1ce953e3
cites cdi_FETCH-LOGICAL-c443t-d0e2ba3a2723f70522468b6a84fb15b6b9da7624ace2538306a3e45ee1ce953e3
container_end_page 826
container_issue 5
container_start_page 813
container_title Journal of Crohn's and colitis
container_volume 15
creator Gallagher, Kate
Catesson, Alexandra
Griffin, Julian L
Holmes, Elaine
Williams, Horace R T
description Abstract Background and Aims The inflammatory bowel diseases [IBD], Crohn’s disease and ulcerative colitis, are chronic, idiopathic gastrointestinal diseases. Although their precise aetiology is unknown, it is thought to involve a complex interaction between genetic predisposition and an abnormal host immune response to environmental exposures, probably microbial. Microbial dysbiosis has frequently been documented in IBD. Metabolomics [the study of small molecular intermediates and end products of metabolism in biological samples] provides a unique opportunity to characterize disease-associated metabolic changes and may be of particular use in quantifying gut microbial metabolism. Numerous metabolomic studies have been undertaken in IBD populations, identifying consistent alterations in a range of molecules across several biological matrices. This systematic review aims to summarize these findings. Methods A comprehensive, systematic search was carried out using Medline and Embase. All studies were reviewed by two authors independently using predefined exclusion criteria. Sixty-four relevant papers were assessed for quality and included in the review. Results Consistent metabolic perturbations were identified, including increases in levels of branched chain amino acids and lipid classes across stool, serum, plasma and tissue biopsy samples, and reduced levels of microbially modified metabolites in both urine [such as hippurate] and stool [such as secondary bile acids] samples. Conclusions This review provides a summary of metabolomic research in IBD to date, highlighting underlying themes of perturbed gut microbial metabolism and mammalian–microbial co-metabolism associated with disease status.
doi_str_mv 10.1093/ecco-jcc/jjaa227
format article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ecco_jcc_jjaa227</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ecco-jcc/jjaa227</oup_id><sourcerecordid>10.1093/ecco-jcc/jjaa227</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-d0e2ba3a2723f70522468b6a84fb15b6b9da7624ace2538306a3e45ee1ce953e3</originalsourceid><addsrcrecordid>eNptkEtLw0AUhQdRbK3uXUn2EjvvybirVWuhIvhYhzvTG0hImpJJLfn3praKC1f3wD3fWXyEXDJ6w6gVY_S-jgvvx0UBwLk5IkOWGB1LaezxdxaxtVIPyFkIBaXKKpOckoEQzCgmkiGZPWMLri7rKvfRZAVlF_IQ5atovspKqCpo66aL7uotltF9HhAC3kaT6K0LLfbPHnrFzxy35-QkgzLgxeGOyMfjw_v0KV68zObTySL2Uoo2XlLkDgRww0VmqOJc6sRpSGTmmHLa2SUYzSV45EokgmoQKBUi82iVQDEidL_rmzqEBrN03eQVNF3KaLpzku6cpL2T9OCkR672yHrjKlz-Aj8S-sL1vlBv1v_OxX_nvgAHqm6s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review</title><source>Oxford Journals Online</source><creator>Gallagher, Kate ; Catesson, Alexandra ; Griffin, Julian L ; Holmes, Elaine ; Williams, Horace R T</creator><creatorcontrib>Gallagher, Kate ; Catesson, Alexandra ; Griffin, Julian L ; Holmes, Elaine ; Williams, Horace R T</creatorcontrib><description>Abstract Background and Aims The inflammatory bowel diseases [IBD], Crohn’s disease and ulcerative colitis, are chronic, idiopathic gastrointestinal diseases. Although their precise aetiology is unknown, it is thought to involve a complex interaction between genetic predisposition and an abnormal host immune response to environmental exposures, probably microbial. Microbial dysbiosis has frequently been documented in IBD. Metabolomics [the study of small molecular intermediates and end products of metabolism in biological samples] provides a unique opportunity to characterize disease-associated metabolic changes and may be of particular use in quantifying gut microbial metabolism. Numerous metabolomic studies have been undertaken in IBD populations, identifying consistent alterations in a range of molecules across several biological matrices. This systematic review aims to summarize these findings. Methods A comprehensive, systematic search was carried out using Medline and Embase. All studies were reviewed by two authors independently using predefined exclusion criteria. Sixty-four relevant papers were assessed for quality and included in the review. Results Consistent metabolic perturbations were identified, including increases in levels of branched chain amino acids and lipid classes across stool, serum, plasma and tissue biopsy samples, and reduced levels of microbially modified metabolites in both urine [such as hippurate] and stool [such as secondary bile acids] samples. Conclusions This review provides a summary of metabolomic research in IBD to date, highlighting underlying themes of perturbed gut microbial metabolism and mammalian–microbial co-metabolism associated with disease status.</description><identifier>ISSN: 1873-9946</identifier><identifier>EISSN: 1876-4479</identifier><identifier>DOI: 10.1093/ecco-jcc/jjaa227</identifier><identifier>PMID: 33175138</identifier><language>eng</language><publisher>UK: Oxford University Press</publisher><ispartof>Journal of Crohn's and colitis, 2021-05, Vol.15 (5), p.813-826</ispartof><rights>The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com 2020</rights><rights>The Author(s) 2020. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-d0e2ba3a2723f70522468b6a84fb15b6b9da7624ace2538306a3e45ee1ce953e3</citedby><cites>FETCH-LOGICAL-c443t-d0e2ba3a2723f70522468b6a84fb15b6b9da7624ace2538306a3e45ee1ce953e3</cites><orcidid>0000-0003-2615-3112</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33175138$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gallagher, Kate</creatorcontrib><creatorcontrib>Catesson, Alexandra</creatorcontrib><creatorcontrib>Griffin, Julian L</creatorcontrib><creatorcontrib>Holmes, Elaine</creatorcontrib><creatorcontrib>Williams, Horace R T</creatorcontrib><title>Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review</title><title>Journal of Crohn's and colitis</title><addtitle>J Crohns Colitis</addtitle><description>Abstract Background and Aims The inflammatory bowel diseases [IBD], Crohn’s disease and ulcerative colitis, are chronic, idiopathic gastrointestinal diseases. Although their precise aetiology is unknown, it is thought to involve a complex interaction between genetic predisposition and an abnormal host immune response to environmental exposures, probably microbial. Microbial dysbiosis has frequently been documented in IBD. Metabolomics [the study of small molecular intermediates and end products of metabolism in biological samples] provides a unique opportunity to characterize disease-associated metabolic changes and may be of particular use in quantifying gut microbial metabolism. Numerous metabolomic studies have been undertaken in IBD populations, identifying consistent alterations in a range of molecules across several biological matrices. This systematic review aims to summarize these findings. Methods A comprehensive, systematic search was carried out using Medline and Embase. All studies were reviewed by two authors independently using predefined exclusion criteria. Sixty-four relevant papers were assessed for quality and included in the review. Results Consistent metabolic perturbations were identified, including increases in levels of branched chain amino acids and lipid classes across stool, serum, plasma and tissue biopsy samples, and reduced levels of microbially modified metabolites in both urine [such as hippurate] and stool [such as secondary bile acids] samples. Conclusions This review provides a summary of metabolomic research in IBD to date, highlighting underlying themes of perturbed gut microbial metabolism and mammalian–microbial co-metabolism associated with disease status.</description><issn>1873-9946</issn><issn>1876-4479</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNptkEtLw0AUhQdRbK3uXUn2EjvvybirVWuhIvhYhzvTG0hImpJJLfn3praKC1f3wD3fWXyEXDJ6w6gVY_S-jgvvx0UBwLk5IkOWGB1LaezxdxaxtVIPyFkIBaXKKpOckoEQzCgmkiGZPWMLri7rKvfRZAVlF_IQ5atovspKqCpo66aL7uotltF9HhAC3kaT6K0LLfbPHnrFzxy35-QkgzLgxeGOyMfjw_v0KV68zObTySL2Uoo2XlLkDgRww0VmqOJc6sRpSGTmmHLa2SUYzSV45EokgmoQKBUi82iVQDEidL_rmzqEBrN03eQVNF3KaLpzku6cpL2T9OCkR672yHrjKlz-Aj8S-sL1vlBv1v_OxX_nvgAHqm6s</recordid><startdate>20210504</startdate><enddate>20210504</enddate><creator>Gallagher, Kate</creator><creator>Catesson, Alexandra</creator><creator>Griffin, Julian L</creator><creator>Holmes, Elaine</creator><creator>Williams, Horace R T</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-2615-3112</orcidid></search><sort><creationdate>20210504</creationdate><title>Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review</title><author>Gallagher, Kate ; Catesson, Alexandra ; Griffin, Julian L ; Holmes, Elaine ; Williams, Horace R T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-d0e2ba3a2723f70522468b6a84fb15b6b9da7624ace2538306a3e45ee1ce953e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gallagher, Kate</creatorcontrib><creatorcontrib>Catesson, Alexandra</creatorcontrib><creatorcontrib>Griffin, Julian L</creatorcontrib><creatorcontrib>Holmes, Elaine</creatorcontrib><creatorcontrib>Williams, Horace R T</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of Crohn's and colitis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gallagher, Kate</au><au>Catesson, Alexandra</au><au>Griffin, Julian L</au><au>Holmes, Elaine</au><au>Williams, Horace R T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review</atitle><jtitle>Journal of Crohn's and colitis</jtitle><addtitle>J Crohns Colitis</addtitle><date>2021-05-04</date><risdate>2021</risdate><volume>15</volume><issue>5</issue><spage>813</spage><epage>826</epage><pages>813-826</pages><issn>1873-9946</issn><eissn>1876-4479</eissn><abstract>Abstract Background and Aims The inflammatory bowel diseases [IBD], Crohn’s disease and ulcerative colitis, are chronic, idiopathic gastrointestinal diseases. Although their precise aetiology is unknown, it is thought to involve a complex interaction between genetic predisposition and an abnormal host immune response to environmental exposures, probably microbial. Microbial dysbiosis has frequently been documented in IBD. Metabolomics [the study of small molecular intermediates and end products of metabolism in biological samples] provides a unique opportunity to characterize disease-associated metabolic changes and may be of particular use in quantifying gut microbial metabolism. Numerous metabolomic studies have been undertaken in IBD populations, identifying consistent alterations in a range of molecules across several biological matrices. This systematic review aims to summarize these findings. Methods A comprehensive, systematic search was carried out using Medline and Embase. All studies were reviewed by two authors independently using predefined exclusion criteria. Sixty-four relevant papers were assessed for quality and included in the review. Results Consistent metabolic perturbations were identified, including increases in levels of branched chain amino acids and lipid classes across stool, serum, plasma and tissue biopsy samples, and reduced levels of microbially modified metabolites in both urine [such as hippurate] and stool [such as secondary bile acids] samples. Conclusions This review provides a summary of metabolomic research in IBD to date, highlighting underlying themes of perturbed gut microbial metabolism and mammalian–microbial co-metabolism associated with disease status.</abstract><cop>UK</cop><pub>Oxford University Press</pub><pmid>33175138</pmid><doi>10.1093/ecco-jcc/jjaa227</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-2615-3112</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1873-9946
ispartof Journal of Crohn's and colitis, 2021-05, Vol.15 (5), p.813-826
issn 1873-9946
1876-4479
language eng
recordid cdi_crossref_primary_10_1093_ecco_jcc_jjaa227
source Oxford Journals Online
title Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A01%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolomic%20Analysis%20in%20Inflammatory%20Bowel%20Disease:%20A%20Systematic%20Review&rft.jtitle=Journal%20of%20Crohn's%20and%20colitis&rft.au=Gallagher,%20Kate&rft.date=2021-05-04&rft.volume=15&rft.issue=5&rft.spage=813&rft.epage=826&rft.pages=813-826&rft.issn=1873-9946&rft.eissn=1876-4479&rft_id=info:doi/10.1093/ecco-jcc/jjaa227&rft_dat=%3Coup_cross%3E10.1093/ecco-jcc/jjaa227%3C/oup_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c443t-d0e2ba3a2723f70522468b6a84fb15b6b9da7624ace2538306a3e45ee1ce953e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/33175138&rft_oup_id=10.1093/ecco-jcc/jjaa227&rfr_iscdi=true